Skip to main content
Erschienen in: Canadian Journal of Anesthesia/Journal canadien d'anesthésie 6/2010

01.06.2010 | Reports of Original Investigations

Glycosylated hemoglobin levels and outcome in non-diabetic cardiac surgery patients

verfasst von: Christopher C. C. Hudson, MD, Ian J. Welsby, MBBS, Barbara Phillips-Bute, PhD, Joseph P. Mathew, MD, Andrew Lutz, MD, G. Chad Hughes, MD, Mark Stafford-Smith, MD, for members of the Cardiothoracic Anesthesiology Research Endeavors (C.A.R.E.) Group

Erschienen in: Canadian Journal of Anesthesia/Journal canadien d'anesthésie | Ausgabe 6/2010

Einloggen, um Zugang zu erhalten

Abstract

Purpose

In diabetics, elevated preoperative hemoglobin A1c (HbA1c) levels are associated with increased complication rates after cardiac surgery. While many non-diabetics also have elevated HbA1c, the relationship with outcome in these patients is not well understood. Therefore, in a cohort of non-diabetic patients, we tested the hypothesis that preoperative HbA1c is associated with early mortality risk after cardiac surgery.

Methods

In this retrospective observational study, we accessed data from a prospectively collected quality assurance database for a cohort of 1,474 non-diabetic elective cardiac surgery patients with documented preoperative HbA1c levels. The relationship of HbA1c with death within 30 days of surgery was examined using logistic regression modeling. Acute kidney injury and infection were similarly assessed using multivariable linear and logistic regression.

Results

Thirty-one percent of patients (n = 456) had elevated HbA1c values (>6.0%). Patients with elevated HbA1c had higher fasting and peak intraoperative blood glucose values. Also, an elevated HbA1c level was independently associated with increased 30-day mortality (odds ratio 1.53 per percent increase [1.24-1.91]; P = 0.0005). This relationship persisted even after “borderline” diabetics were excluded. Furthermore, acute kidney injury was associated with elevated baseline HbA1c (P = 0.01). No association was found between HbA1c and postoperative infection risk (P = 0.48).

Conclusion

In non-diabetics, an elevated preoperative HbA1c level (>6.0%) is independently associated with significantly greater early mortality risk after elective cardiac surgery. Our findings suggest that HbA1c may have value as a screening tool to identify high-risk non-diabetic cardiac surgery patients.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Rosamond W, Flegal K, Furie K, et al. Heart disease and stroke statistics–2008 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2008; 117: e25-146.CrossRefPubMed Rosamond W, Flegal K, Furie K, et al. Heart disease and stroke statistics–2008 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2008; 117: e25-146.CrossRefPubMed
2.
Zurück zum Zitat Nashef SA, Roques F, Michel P, Gauducheau E, Lemeshow S, Salamon R. European system for cardiac operative risk evaluation (EuroSCORE). Eur J Cardiothorac Surg 1999; 16: 9-13.CrossRefPubMed Nashef SA, Roques F, Michel P, Gauducheau E, Lemeshow S, Salamon R. European system for cardiac operative risk evaluation (EuroSCORE). Eur J Cardiothorac Surg 1999; 16: 9-13.CrossRefPubMed
3.
Zurück zum Zitat Parsonnet V, Dean D, Bernstein AD. A method of uniform stratification of risk for evaluating the results of surgery in acquired adult heart disease. Circulation 1989; 79: I3-12.PubMed Parsonnet V, Dean D, Bernstein AD. A method of uniform stratification of risk for evaluating the results of surgery in acquired adult heart disease. Circulation 1989; 79: I3-12.PubMed
4.
Zurück zum Zitat Nilsson J, Algotsson L, Hoglund P, Luhrs C, Brandt J. Comparison of 19 pre-operative risk stratification models in open-heart surgery. Eur Heart J 2006; 27: 867-74.CrossRefPubMed Nilsson J, Algotsson L, Hoglund P, Luhrs C, Brandt J. Comparison of 19 pre-operative risk stratification models in open-heart surgery. Eur Heart J 2006; 27: 867-74.CrossRefPubMed
5.
Zurück zum Zitat Thourani VH, Weintraub WS, Stein B, et al. Influence of diabetes mellitus on early and late outcome after coronary artery bypass grafting. Ann Thorac Surg 1999; 67: 1045-52.CrossRefPubMed Thourani VH, Weintraub WS, Stein B, et al. Influence of diabetes mellitus on early and late outcome after coronary artery bypass grafting. Ann Thorac Surg 1999; 67: 1045-52.CrossRefPubMed
6.
Zurück zum Zitat Carson JL, Scholz PM, Chen AY, Peterson ED, Gold J, Schneider SH. Diabetes mellitus increases short-term mortality and morbidity in patients undergoing coronary artery bypass graft surgery. J Am Coll Cardiol 2002; 40: 418-23.CrossRefPubMed Carson JL, Scholz PM, Chen AY, Peterson ED, Gold J, Schneider SH. Diabetes mellitus increases short-term mortality and morbidity in patients undergoing coronary artery bypass graft surgery. J Am Coll Cardiol 2002; 40: 418-23.CrossRefPubMed
7.
Zurück zum Zitat Kubal C, Srinivasan AK, Grayson AD, Fabri BM, Chalmers JA. Effect of risk-adjusted diabetes on mortality and morbidity after coronary artery bypass surgery. Ann Thorac Surg 2005; 79: 1570-6.CrossRefPubMed Kubal C, Srinivasan AK, Grayson AD, Fabri BM, Chalmers JA. Effect of risk-adjusted diabetes on mortality and morbidity after coronary artery bypass surgery. Ann Thorac Surg 2005; 79: 1570-6.CrossRefPubMed
8.
Zurück zum Zitat Furnary AP, Zerr KJ, Grunkemeier GL, Starr A. Continuous intravenous insulin infusion reduces the incidence of deep sternal wound infection in diabetic patients after cardiac surgical procedures. Ann Thorac Surg 1999; 67: 352-60. discussion 60-2.CrossRefPubMed Furnary AP, Zerr KJ, Grunkemeier GL, Starr A. Continuous intravenous insulin infusion reduces the incidence of deep sternal wound infection in diabetic patients after cardiac surgical procedures. Ann Thorac Surg 1999; 67: 352-60. discussion 60-2.CrossRefPubMed
9.
Zurück zum Zitat Lazar HL, Chipkin SR, Fitzgerald CA, Bao Y, Cabral H, Apstein CS. Tight glycemic control in diabetic coronary artery bypass graft patients improves perioperative outcomes and decreases recurrent ischemic events. Circulation 2004; 109: 1497-502.CrossRefPubMed Lazar HL, Chipkin SR, Fitzgerald CA, Bao Y, Cabral H, Apstein CS. Tight glycemic control in diabetic coronary artery bypass graft patients improves perioperative outcomes and decreases recurrent ischemic events. Circulation 2004; 109: 1497-502.CrossRefPubMed
10.
Zurück zum Zitat van den Berghe G, Wouters P, Weekers F, et al. Intensive insulin therapy in the critically ill patients. N Engl J Med 2001; 345: 1359-67.CrossRefPubMed van den Berghe G, Wouters P, Weekers F, et al. Intensive insulin therapy in the critically ill patients. N Engl J Med 2001; 345: 1359-67.CrossRefPubMed
11.
Zurück zum Zitat Griesdale DE, de Souza RJ, van Dam RM, et al. Intensive insulin therapy and mortality among critically ill patients: a meta-analysis including NICE-SUGAR study data. CMAJ 2009; 180: 821-7.PubMed Griesdale DE, de Souza RJ, van Dam RM, et al. Intensive insulin therapy and mortality among critically ill patients: a meta-analysis including NICE-SUGAR study data. CMAJ 2009; 180: 821-7.PubMed
12.
Zurück zum Zitat Reinhart K, Brunkhorst FM, Engel C, et al. Study protocol of the VISEP study. Response of the SepNet study group (German). Anaesthesist 2008; 57: 723-8.CrossRefPubMed Reinhart K, Brunkhorst FM, Engel C, et al. Study protocol of the VISEP study. Response of the SepNet study group (German). Anaesthesist 2008; 57: 723-8.CrossRefPubMed
13.
Zurück zum Zitat American Diabetes Association. Standards of medical care in diabetes. Diabetes Care 2005; 28(Suppl 1): S4-36.CrossRef American Diabetes Association. Standards of medical care in diabetes. Diabetes Care 2005; 28(Suppl 1): S4-36.CrossRef
14.
Zurück zum Zitat Saudek CD, Derr RL, Kalyani RR. Assessing glycemia in diabetes using self-monitoring blood glucose and hemoglobin A1c. JAMA 2006; 295: 1688-97.CrossRefPubMed Saudek CD, Derr RL, Kalyani RR. Assessing glycemia in diabetes using self-monitoring blood glucose and hemoglobin A1c. JAMA 2006; 295: 1688-97.CrossRefPubMed
15.
Zurück zum Zitat Halkos ME, Lattouf OM, Puskas JD, et al. Elevated preoperative hemoglobin A1c level is associated with reduced long-term survival after coronary artery bypass surgery. Ann Thorac Surg 2008; 86: 1431-7.CrossRefPubMed Halkos ME, Lattouf OM, Puskas JD, et al. Elevated preoperative hemoglobin A1c level is associated with reduced long-term survival after coronary artery bypass surgery. Ann Thorac Surg 2008; 86: 1431-7.CrossRefPubMed
16.
Zurück zum Zitat Halkos ME, Puskas JD, Lattouf OM, et al. Elevated preoperative hemoglobin A1c level is predictive of adverse events after coronary artery bypass surgery. J Thorac Cardiovasc Surg 2008; 136: 631-40.CrossRefPubMed Halkos ME, Puskas JD, Lattouf OM, et al. Elevated preoperative hemoglobin A1c level is predictive of adverse events after coronary artery bypass surgery. J Thorac Cardiovasc Surg 2008; 136: 631-40.CrossRefPubMed
17.
Zurück zum Zitat Khaw KT, Wareham N, Bingham S, Luben R, Welch A, Day N. Association of hemoglobin A1c with cardiovascular disease and mortality in adults: the European prospective investigation into cancer in Norfolk. Ann Intern Med 2004; 141: 413-20.PubMed Khaw KT, Wareham N, Bingham S, Luben R, Welch A, Day N. Association of hemoglobin A1c with cardiovascular disease and mortality in adults: the European prospective investigation into cancer in Norfolk. Ann Intern Med 2004; 141: 413-20.PubMed
18.
Zurück zum Zitat O’Sullivan CJ, Hynes N, Mahendran B, et al. Haemoglobin A1c (HbA1C) in non-diabetic and diabetic vascular patients. Is HbA1C an independent risk factor and predictor of adverse outcome? Eur J Vasc Endovasc Surg 2006; 32: 188-97.CrossRefPubMed O’Sullivan CJ, Hynes N, Mahendran B, et al. Haemoglobin A1c (HbA1C) in non-diabetic and diabetic vascular patients. Is HbA1C an independent risk factor and predictor of adverse outcome? Eur J Vasc Endovasc Surg 2006; 32: 188-97.CrossRefPubMed
19.
Zurück zum Zitat Corpus RA, O’Neill WW, Dixon SR, Timmis GC, Devlin WH. Relation of hemoglobin A1c to rate of major adverse cardiac events in nondiabetic patients undergoing percutaneous coronary revascularization. Am J Cardiol 2003; 92: 1282-6.CrossRefPubMed Corpus RA, O’Neill WW, Dixon SR, Timmis GC, Devlin WH. Relation of hemoglobin A1c to rate of major adverse cardiac events in nondiabetic patients undergoing percutaneous coronary revascularization. Am J Cardiol 2003; 92: 1282-6.CrossRefPubMed
20.
Zurück zum Zitat Engoren M, Habib RH, Zacharias A, et al. The prevalence of elevated hemoglobin A1c in patients undergoing coronary artery bypass surgery. J Cardiothorac Surg 2008; 3: 63.CrossRefPubMed Engoren M, Habib RH, Zacharias A, et al. The prevalence of elevated hemoglobin A1c in patients undergoing coronary artery bypass surgery. J Cardiothorac Surg 2008; 3: 63.CrossRefPubMed
21.
Zurück zum Zitat Buckberg GD, Beyersdorf F, Allen BS, Robertson JM. Integrated myocardial management: background and initial application. J Card Surg 1995; 10: 68-89.CrossRefPubMed Buckberg GD, Beyersdorf F, Allen BS, Robertson JM. Integrated myocardial management: background and initial application. J Card Surg 1995; 10: 68-89.CrossRefPubMed
22.
Zurück zum Zitat Bellomo R, Ronco C, Kellum JA, Mehta RL, Palevsky P; Acute Dialysis Quality Initiative workgroup. Acute renal failure - definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care 2004; 8: R204-12.CrossRefPubMed Bellomo R, Ronco C, Kellum JA, Mehta RL, Palevsky P; Acute Dialysis Quality Initiative workgroup. Acute renal failure - definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care 2004; 8: R204-12.CrossRefPubMed
23.
Zurück zum Zitat Thakar CV, Arrigain S, Worley S, Yared JP, Paganini EP. A clinical score to predict acute renal failure after cardiac surgery. J Am Soc Nephrol 2005; 16: 162-8.CrossRefPubMed Thakar CV, Arrigain S, Worley S, Yared JP, Paganini EP. A clinical score to predict acute renal failure after cardiac surgery. J Am Soc Nephrol 2005; 16: 162-8.CrossRefPubMed
24.
Zurück zum Zitat Chertow GM, Lazarus JM, Christiansen CL, et al. Preoperative renal risk stratification. Circulation 1997; 95: 878-84.PubMed Chertow GM, Lazarus JM, Christiansen CL, et al. Preoperative renal risk stratification. Circulation 1997; 95: 878-84.PubMed
25.
Zurück zum Zitat Wijeysundera DN, Karkouti K, Dupuis JY, et al. Derivation and validation of a simplified predictive index for renal replacement therapy after cardiac surgery. JAMA 2007; 297: 1801-9.CrossRefPubMed Wijeysundera DN, Karkouti K, Dupuis JY, et al. Derivation and validation of a simplified predictive index for renal replacement therapy after cardiac surgery. JAMA 2007; 297: 1801-9.CrossRefPubMed
26.
Zurück zum Zitat Palomba H, de Castro I, Neto AL, Lage S, Yu L. Acute kidney injury prediction following elective cardiac surgery: AKICS Score. Kidney Int 2007; 72: 624-31.CrossRefPubMed Palomba H, de Castro I, Neto AL, Lage S, Yu L. Acute kidney injury prediction following elective cardiac surgery: AKICS Score. Kidney Int 2007; 72: 624-31.CrossRefPubMed
27.
Zurück zum Zitat Collier B, Dossett LA, May AK, Diaz JJ. Glucose control and the inflammatory response. Nutr Clin Pract 2008; 23: 3-15.CrossRefPubMed Collier B, Dossett LA, May AK, Diaz JJ. Glucose control and the inflammatory response. Nutr Clin Pract 2008; 23: 3-15.CrossRefPubMed
28.
Zurück zum Zitat Selvin E, Zhu H, Brancati FL. Elevated A1C in adults without a history of diabetes in the U.S. Diabetes Care 2009; 32: 828-33.CrossRefPubMed Selvin E, Zhu H, Brancati FL. Elevated A1C in adults without a history of diabetes in the U.S. Diabetes Care 2009; 32: 828-33.CrossRefPubMed
29.
Zurück zum Zitat Anonymous. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group. N Engl J Med 1993; 329: 977-86.CrossRef Anonymous. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group. N Engl J Med 1993; 329: 977-86.CrossRef
30.
Zurück zum Zitat Anonymous. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group. Lancet 1998; 352: 854-65.CrossRef Anonymous. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group. Lancet 1998; 352: 854-65.CrossRef
31.
Zurück zum Zitat Anonymous. Incidence and prevalence of ESRD United States Renal Data System. Am J Kidney Dis 1998; 32: S38-49.CrossRef Anonymous. Incidence and prevalence of ESRD United States Renal Data System. Am J Kidney Dis 1998; 32: S38-49.CrossRef
32.
Zurück zum Zitat Nakanishi S, Yamada M, Hattori N, Suzuki G. Relationship between HbA(1)c and mortality in a Japanese population. Diabetologia 2005; 48: 230-4.CrossRefPubMed Nakanishi S, Yamada M, Hattori N, Suzuki G. Relationship between HbA(1)c and mortality in a Japanese population. Diabetologia 2005; 48: 230-4.CrossRefPubMed
33.
Zurück zum Zitat Medhi M, Marshall MC Jr, Burke HB, et al. HbA1c predicts length of stay in patients admitted for coronary artery bypass surgery. Heart Dis 2001; 3: 77-9.CrossRefPubMed Medhi M, Marshall MC Jr, Burke HB, et al. HbA1c predicts length of stay in patients admitted for coronary artery bypass surgery. Heart Dis 2001; 3: 77-9.CrossRefPubMed
34.
Zurück zum Zitat Anderson RE, Klerdal K, Ivert T, Hammar N, Barr G, Owall A. Are even impaired fasting blood glucose levels preoperatively associated with increased mortality after CABG surgery? Eur Heart J 2005; 26: 1513-8.CrossRefPubMed Anderson RE, Klerdal K, Ivert T, Hammar N, Barr G, Owall A. Are even impaired fasting blood glucose levels preoperatively associated with increased mortality after CABG surgery? Eur Heart J 2005; 26: 1513-8.CrossRefPubMed
35.
Zurück zum Zitat Paul M, Raz A, Leibovici L, Madar H, Holinger R, Rubinovitch B. Sternal wound infection after coronary artery bypass graft surgery: validation of existing risk scores. J Thorac Cardiovasc Surg 2007; 133: 397-403.CrossRefPubMed Paul M, Raz A, Leibovici L, Madar H, Holinger R, Rubinovitch B. Sternal wound infection after coronary artery bypass graft surgery: validation of existing risk scores. J Thorac Cardiovasc Surg 2007; 133: 397-403.CrossRefPubMed
Metadaten
Titel
Glycosylated hemoglobin levels and outcome in non-diabetic cardiac surgery patients
verfasst von
Christopher C. C. Hudson, MD
Ian J. Welsby, MBBS
Barbara Phillips-Bute, PhD
Joseph P. Mathew, MD
Andrew Lutz, MD
G. Chad Hughes, MD
Mark Stafford-Smith, MD
for members of the Cardiothoracic Anesthesiology Research Endeavors (C.A.R.E.) Group
Publikationsdatum
01.06.2010
Verlag
Springer-Verlag
Erschienen in
Canadian Journal of Anesthesia/Journal canadien d'anesthésie / Ausgabe 6/2010
Print ISSN: 0832-610X
Elektronische ISSN: 1496-8975
DOI
https://doi.org/10.1007/s12630-010-9294-4

Weitere Artikel der Ausgabe 6/2010

Canadian Journal of Anesthesia/Journal canadien d'anesthésie 6/2010 Zur Ausgabe

Update AINS

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.